 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Krebs Biochemicals & Industries Ltd at its meeting held on Monday, 25th March 2019 has approved the allotment of 28,86,300 equity shares as per the basis of allotment approved by BSE Limited (the Designated Stock Exchange) on 22nd March 2019. Further, the paid-up equity share capital of the Company amounts to Rs. 16,63,05,860/- divided into 1,66,30,586 equity shares of Rs. 10/- each.
Shares of KREBS BIOCHEMICALS & INDUSTRIES LTD. was last trading in BSE at Rs.93.25 as compared to the previous close of Rs. 94.4. The total number of shares traded during the day was 526 in over 10 trades.
The stock hit an intraday high of Rs. 96.5 and intraday low of 93. The net turnover during the day was Rs. 49581.